Isabl
PrivateLast Round
Grant
Mar 8, 2024
Est. Valuation
$2.14M
Total Funding Raised
$6.22M
Company Overview
Isabl operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Grant round in March 2024.
Isabl is a biotechnology company that has developed a medical diagnosis platform to analyze the entire genome and transcriptome of cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Isabl Comparables
Compare Isabl with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BostonGene | 77% | |
| OncoDNA | 76% | |
| GenomOncology | 75% |
For institutional investors. Book with your work email.
Isabl Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 8, 2024 | ||||
| Seed | May 18, 2022 | ||||
| Grant | Apr 1, 2022 | ||||
| Accelerator | Apr 3, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Isabl Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Two Sigma Ventures | Seed |
| BoxOne Ventures | Seed |
| Y Combinator | Seed, Accelerator |
| Evolution VC Partners | Seed |
| Sand Hill Angels | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2022
$3M round led by Two Sigma Ventures and Deviation Capital.
- Apr 1, 2022
$1M grant received from the National Cancer Institute.
For institutional investors. Book with your work email.
Isabl Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Isabl's valuation, stock price, and market status.
Is Isabl a public or private company?
Isabl is a private company.
What is the current stock price of Isabl?
Isabl is a private company, so its shares have no public market price. Caplight tracks Isabl's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Isabl worth (valuation)?
Isabl's valuation is estimated at $2.1M based on funding round data.
Can I buy Isabl stock?
Isabl shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Isabl's last funding round?
Isabl's most recent funding round was Grant on March 8, 2024.
Who are the main investors in Isabl?
Key investors in Isabl include National Cancer Institute, Two Sigma Ventures.
Will Isabl IPO soon?
No public IPO plans have been announced for Isabl.
How can I track Isabl secondary market activity?
Caplight tracks bids, offers, and trades in Isabl's shares on secondary markets.